Aprotinin concentrated solution

Hazard statements (CLP)

H317, H334

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Health hazards

Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled Skin Sens. 1 H317 May cause an allergic skin reaction

Hazard pictograms

GHS08

Signal word

Danger

Hazardous Ingredients

Aprotinin (Contd. of page 1)

Hazard statements

H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction.

Precautionary statements

P261 Avoid breathing mist/vapours/spray. P280 Wear protective gloves / protective clothing. P285 In case of inadequate ventilation wear respiratory protection. P304+P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P342+P311 If experiencing respiratory symptoms: Call a POISON CENTER/doctor.

PBT Substances

According to current knowledge, the product contains no PBT substance

vPvB Substances

According to current knowledge, the product contains no vPvB substance Determination of endocrine-disrupting properties Taking into account the current state of scientific knowledge, no data on endocrine disrupting properties of the product are available.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 health hazard Resp. Sens. 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin Sens. 1 H317 May cause an allergic skin reaction.